Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade Publisher Pubmed



Taheri D1, 2 ; Jahanshahi F2, 3 ; Khajavi A4 ; Kafi F2 ; Pouramini A2 ; Farsani RM2 ; Alizadeh Y5 ; Akbarzadeh M6 ; Reis LO7 ; Khatami F2 ; Aghamir SMK2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Kidney Disease Research Center, Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Research Committee Member, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Student Research Committee, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Department of Pathology, Moheb-Mehr Hospital, Tehran, Iran
  6. 6. Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Netherlands
  7. 7. UroScience and Department of Surgery (Urology), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, Sao Paulo, Campinas, Brazil

Source: Clinical Genitourinary Cancer Published:2023


Abstract

Introduction: Our study aims to evaluate the impact of the COVID-19 pandemic on the number of uro-oncological surgeries (cystectomy, nephrectomy, prostatectomy, orchiectomy, and transurethral resection of bladder tumor (TURBT)) and pathological staging and grading. Materials and Methods: The present study is a retrospective study on patients with genitourinary cancers treated from 2018 to 2021 in a referral tertiary center. The data were obtained from the hospital records with lengths of 22 and 23 months, labeled hereafter as non-COVID and COVID pandemic, respectively (2018/3/21-2020/1/20 and 2020/1/21-2021/12/21). The total number of registered patients, gender, age, stage, and grade were compared in the targeted periods. Moreover, all the pathologic slides were reviewed by an expert uropathologist before enrolling in the study. The continuous and discrete variables are reported as mean (standard deviation (SD)) and number (percent) and the χ2 test for the comparison of the discrete variables' distribution. Results: In this study total number of 2077 patients were enrolled. The number of procedures performed decreased during the Covid pandemic. The tumors' distribution stage and grade and patients' baseline characteristics were not significantly different in non-COVID and COVID pandemic periods for Radical Nephrectomy, Radical Cystectomy, Radical Prostatectomy, and orchiectomy. For TURBT only, the tumor stage was significantly different (P-value<.001) from the higher stages in the COVID pandemic period. Conclusion: Among urinary tract cancers, staging of bladder cancer and TURBT are mainly impacted by the COVID-19 pandemic with higher stages compared to the non-COVID period. We evaluate the impact of the COVID-19 pandemic on the number of uro-oncological surgeries based on pathological staging and grading. Total number of 2077 patients were enrolled. Among urinary tract cancers, staging of bladder cancer and TURBT are mainly impacted by the COVID-19 pandemic with higher stages compared to the non-COVID period. © 2022 Elsevier Inc.
1. Investigation of Bladder Cancer Incidence in Isfahan, Iran, Tehran University Medical Journal (2019)
Experts (# of related papers)